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Background: It is likely that people with chronic pain who have low self-efficacy have a worse prognosis. A standard, high quality measure of self-efficacy in such populations would improve evidence, by allowing meaningful comparisons amongst sub-groups and between treatments, and by facilitating pooling across studies in systematic reviews. 
Objectives: To systematically identify self-administered pain-related self-efficacy measures used in people with chronic pain and to evaluate the clinimetric evidence of the most commonly used scales.
Methods: We searched two databases to identify self-efficacy questionnaires. We evaluated questionnaires identified against previously developed criteria for clinimetric assessment.
Results: We identified 13 relevant measurements assessing self-efficacy, and clinimetrically assessed five of these. These questionnaires were the Arthritis Self-Efficacy Scale (ASES), the Chronic Disease Self-Efficacy Scale (CDSES), the Pain Self-Efficacy Questionnaire (PSEQ), the Chronic Pain Self-efficacy Scale (CPSS), and the Self-Efficacy Scale (SES). None of the questionnaires demonstrated satisfactory results for all properties. All scales were easily scored and dimensionality was assessed in 2/6 of the scales. Internal consistency was acceptable for all questionnaires. There was positive evidence for construct validity in 4/6 of the questionnaires. None of the studies used the most up-to-date method of test-retest reliability or responsiveness. Information on interpretability of the scores was minimal in all questionnaires.
Discussion: Further research should focus on assessing responsiveness and interpretability of these questionnaires. Researchers should select questionnaires that are most appropriate for their study aims and population and contribute to further validation of these scales. Future research should measure outcome expectancy alongside self-efficacy to best predict future behaviour.





Chronic pain is a common and costly health problem. The biopsychosocial model of back pain has improved our understanding of the disorder. Several psychological factors, including self-efficacy have affected  prognosis; it may also moderate response to treatment [1]. Self-efficacy is a concept describing a set of beliefs about oneself, specifically about one’s ability to perform certain behaviours within a particular environment [2]. Self-efficacy is not only related to specific behaviours but also to the beliefs that people have about how they can cope in adverse situations [3]. Self-efficacy in people suffering from pain include beliefs about one’s ability to control the pain and the negative emotions associated with it, to maintain everyday life activities including work, to communicate their needs to health carers, and implement advice about their pain. There is  some evidence that higher self-efficacy about managing pain is associated with more positive  treatment outcomes [4],  higher return to work rates [5], better adherence [6], more effective control of pain and affect [7] and better prognosis  ADDIN EN.CITE [8],. It has also been proposed that self-efficacy beliefs mediate the relationship between pain and pain-related disability in different chronic pain samples [9]. 

Test-retest data has demonstrated that self-efficacy is a psychological state that is changeable and therefore modifiable in the context of treatment [10]. Social learning theory suggests that interventions designed to enhance self-efficacy of carrying out specific behaviours will be associated with improved health-related outcomes in those areas affected by those specific behaviours [11]. A systematic review of lay-led self-management interventions for people with chronic conditions found that self-efficacy can be modified and that improvements in self-efficacy can lead to improved quality of life outcomes for patients [12]. Another systematic review [13] looking at self-efficacy as both a predictor and mediator of health-related outcomes after self-management programmes found that more positive outcomes were associated with higher baseline self-efficacy or with changes in self-efficacy as a result of the self-managment intervention (for outcomes including health distress, role-function, pain, disabiliy and physical function). Standardising the measurement of self-efficacy would benefit research, providing the standard measure is comprehensive, and has been shown to be of high clinimetric standards. 
Self-efficacy has been measured through self-report questionnaires. Questionnaire choice is usually determined by factors such as time constraints of the questionnaire battery in a study and the population studied, alongside clinimetric merits of the particular scale. Previous expert consensus studies have made recommendations of measures to improve the quality and completeness of measurement in prospective cohort studies in populations with low back pain and chronic pain  ADDIN EN.CITE [14,15]. These recommendations did not, however, include self-efficacy. There is therefore a gap in the literature recommending a measure of self-efficacy suitable for chronic pain populations. We are not aware of a systematic review of pain-related self-efficacy measures for pain populations followed by clinimetric assessment. 




2.1.	 Stage 1: First search
We searched Medline and PsycInfo (1950 to Sept 2010). We used both keywords and MESH terms   . Limits of human studies and English language were applied. We used the following search terms: [self-efficacy] combined with [scale, inventory, instrument, measure, outcome, questionnaire, outcome assessment, psychometrics] combined with [chronic disease, pain, musculoskeletal diseases, low back pain, fibromyalgia, neck pain, shoulder pain, osteoarthritis, chronic, persistent, long-term, wide-spread, recurrent, non-specific, ongoing or musculoskeletal]. 
Inclusion criteria
We included studies if they were published in a peer-reviewed journal and were used with adults with pain as either a result of chronic disease or musculoskeletal disorders and the item content explicitly included pain-related self-efficacy.

2.2.	 Stage 2: Second search
We selected pain-related self-efficacy measures for further clinimetric focused searching on the basis of the following criteria: 1) The tool was used in at least one study in a pain population (chronic disease or musculoskeletal disorder); 2) The tool was presented in English. The measures that fulfilled these criteria from the first search were selected for focus in a second search; 3) The content of the questionnaire items explicitly included the term ‘pain’. The second search attempted to identify clinimetric evaluation of these self-efficacy measures and used the names of these questionnaires. Search terms used were: [Arthritis self-efficacy, Chronic Disease self-efficacy, Stanford self-efficacy, Pain self-efficacy, PSEQ, Chronic Pain Self-efficacy Scale, CPSS, Self-Efficacy Scale, SES, Movement and Pain-Prediction Scale, or MAPPS] combined with [Test Reliability, exp Psychometrics, exp Test Validity, exp Test Interpretation, validity, reliability, development,  consistency, responsiveness, interpretability, psychometrics, clinimetrics]. The reference lists of the identified psychometric studies were scanned to obtain further psychometric studies.

2.3.	 Stage 3: Clinimetric assessment

We carried out clinimetric assessment on the pain-related self-efficacy questionnaires selected at stage 2. We assessed these studies using the clinimetric criteria adopted from previous research  ADDIN EN.CITE [16,17] and included information regarding the following: Time to administer, ease of scoring, readability and comprehension, content validity, internal consistency, criterion validity, construct validity, reproducibility (agreement and reliability), responsiveness, interpretability and floor/ceiling effects. See Table 3 for scoring criteria and definitions. 
3.0. Results
The first electronic search identified 1520 articles - 180 of these were screened for inclusion in this review. Table 1 presents the questionnaires that were obtained from the first broad search. There were 13 pain-related self-efficacy questionnaires identified in the search (see Table 1). On closer inspection we excluded eight measures as they were either not pain-related self-efficacy measures, leaving six pain-related self-efficacy measures. These were: 1) The Arthritis Self-Efficacy Scale (ASES) [10] and its 2 variants (shorter versions); 2) The Chronic Disease Self-Efficacy Scale (CDSES) [18] and its 1 variant (shorter version); 3) The Pain Self-Efficacy Questionnaire (PSEQ, [19]; 4) The Chronic Pain Self-efficacy Scale (CPSS) [20]; 5) The Self-Efficacy Scale [21]; 6) The Movement and Pain Prediction Scale (MAPPS). 

The second search identified a further 80 references for the ASES, CDSES, PSEQ, CPSS and SES. In the end, 35 references included clinimetric evaluation and 85 references that used the main questionnaires. There were no studies that included clinimetric evaluation of the Movement and Pain Prediction Scale (MAPPS) [22]. See Figure 1 for a detailed search process. 

Descriptives of the questionnaires
There are three versions of the ASES (short and long versions, ASES-20 [10], ASES-11 [10], ASES-8 [10], two Chronic Disease Self-efficacy Scales (short and long versions, CDSES-33 and CDSES-6, [18,23]), the PSEQ [19], the CPSS [20], and the SES (Altmaier, 1993).  Descriptives regarding the domains measured, numbers of scales and items, time to administer, burden of scoring and target populations are presented in table 2. All questionnaires were scored easily as defined by [16]. Time to administer was generally under 10 minutes. Where times were not available for four questionnaires (ASES-20, CPSS, CDSES-30, SES), it is estimated at 10-15 minutes for the ASES-20, CPSS and SES and 15-20 minutes for the CDSES-30. It is also important to note that the CPSS is an adaptation of the original version of the ASES. The items of the ASES were adapted for use with a general chronic pain population and are very similar in item content. The CPSS has two additional items and different behaviours are used to the ASES.

Readability and comprehensibility
Readability and comprehensibility were assessed in 3 questionnaires (PSEQ, ASES-11 and CPSS). No information on either readability or comprehension was provided for the other questionnaires.

Content validity
Ratings regarding the content validity and other clinimetric domains are presented in Table 3. The majority of the questionnaires rated positively for content validity. There was not enough information provided for assessment in the CDSES-6 and the SES.  

Internal consistency




As there is no ‘gold standard’ of self-efficacy measure against which the evaluated questionnaires could be compared, however this quality was assessed where other self-efficacy measures were used as a comparator. None of the questionnaires scored positively on criterion validity. The correlations were <0.70 for the ASES-20 and ASES-11. The method was doubtful or there was no justification given for using the comparator self-efficacy measure with the CDSES-33. There was not enough information provided for assessing criterion validity on the ASES-8, CDSES-6, PSEQ, CPSS and SES.

Construct validity




To calculate the agreement of a questionnaire the minimal important change (MIC) and the smallest detectable change (SDC) should be provided by the researchers constructing the questionnaire. This information was not provided for all questionnaires reviewed here and so agreement could not be calculated.

ii)	Reliability
Test-retest reliability was assessed for four out of the eight questionnaires (ASES-20, CDSES-33, PSEQ, and CPSS). Time intervals between test administrations were between three days and 16.3 weeks. Test-retest correlations ranged from .68 to .88 across the four questionnaires.  Pearson’s product correlations were used to assess test-retest reliability for the ASES-20, CDSES-33 and PSEQ, however the intra-class correlation coefficient (ICC) is thought to be the most adequate test of retest-reliability [25] and was carried out for the CPSS only. 

Responsiveness 
The responsiveness of five of the questionnaires (ASES-20, CDSES-33, PSEQ, CPSS and SES) was evaluated in eight studies. Hypotheses were given from all studies (except Burckhardt 1994 [26]) regarding a specific change in self-efficacy in association with the intervention (note that a change was explored in Nicholas 1992 [19], not predicted). No data on responsiveness were found for the other three questionnaires (ASES-11, ASES-8, CDSES-6). Recent recommendations suggest that an adequate way to analyse responsiveness is through ROC curve analysis or by relating the SDC to the MIC  [17]. No study used these techniques to analyse responsiveness and so there were no positive ratings given for this measure.

Floor/ceiling effects
Floor and ceiling effects were evaluated for the ASES-8 and CDSES-33 by calculating the proportions of the sample that had the lowest and highest possible scores.  Both questionnaires were free from floor effects, although minimal ceiling effects was reported for the CDSES-33. Such information was missing for the ASES-20, ASES-11, CDSES-6, PSEQ, CPSS and SES.

Interpretability
None of the questionnaires scored positively for providing adequate interpretability data. Although baseline and post-means were given for three questionnaires (ASES-20, CDSES-33, PSEQ, and CPSS) and  scores of a relevant subgroup was described for the PSEQ,  Minimal Clinically Important Differences (MCID) were not reported for any of the self-efficacy measures and there was no interpretability data available for the other four questionnaires (ASES-11, ASES-8, CDSES-6 or SES). 

Versions in other languages
The PSEQ has been translated into Persian, Portuguese and Chinese  ADDIN EN.CITE [27-29]; the ASES has Swedish, Spanish and German versions  ADDIN EN.CITE [30-33]; the CPSS has Spanish and Chinese versions [34,35]; and the SES has a Swedish version [36].
Discussion 
To our knowledge, this study was the first to systematically search pain-related self-efficacy questionnaires and carry out clinimetric assessment of them. This review did not intend to provide recommendation of the ‘best’ tool to use in research but rather to provide information to researchers about the range of pain-related self-efficacy questionnaires and their clinimetric qualities to aid selection. 
We identified 13 pain-related self-efficacy questionnaires and clinimetrically assessed five (eight, including variants) of these questionnaires (ASES, CDSES, PSEQ, CPSS, and SES). These questionnaires were identified as being used in those with pain as a result of chronic disease or musculoskeletal disorders. Three questionnaires (CDSES, CPSS and PSEQ) are more suitable for chronic pain populations in general. For the development of these questionnaires, the CDSES used a heterogeneous pain group, whereas for the PSEQ and CPSS the populations were predominantly those with musculoskeletal disorders. The ASES was designed specifically for patients with Arthritis and the SES was developed in a low back pain population. The populations in which the questionnaires were validated in should be considered when selecting measures for use in other populations. Furthermore, this review is limited to these populations and should not be generalized to other pain populations. 
Future research should aim to explore the meaning of different score ranges within each questionnaire. This would improve understanding by relating scores to clinical status. None of the studies provided MCIDs. The MCID is "the smallest (absolute) difference in score which patients perceive as beneficial and which would mandate, in the absence of troublesome side-effects and excessive cost, a change in the patient's management". http://www.jrheum.com/subscribers/07/03/463.html  [37]. There have been developments in the assessment of MCID  ADDIN EN.CITE [38], which now split the analysis into a Minimal Important Difference (MID) and Minimal Important Change (MIC), however none of the questionnaires in this study measured either. For some of the questionnaires there was some information that could assist with interpretation of the scores, such as presentation of means and standard deviations of patient scores before and after treatment, however information regarding relevant subgroups was provided for the PSEQ only.
Overall, there was disappointment that these are not better validated but inadequate validation is common across a range of domains that are measured via self-report questionnaires. Based on the review of these questionnaires we make recommendations for future researchers carrying out validation of questionnaires of self-efficacy: 1) Factor structures of questionnaires should be explored and confirmed; 2) When testing construct validity specify directional hypotheses; 3) Provide descriptive statistics for distribution of scores for adequate evaluation of floor/ceiling effects; 4) Test-retest data and inter-rater reliability data using adequate statistical procedures need to be carried out; 5) Information regarding the interpretability of scores should be provided or other information such as scores of relevant subgroups and means and SDs to aid comparability and responsiveness. 
The research team for the present review decided upon aspects thought to be important in self-efficacy in pain populations. These are outlined in the introduction as beliefs about one’s ability to control the pain and the negative emotions associated with it; to maintain everyday life activities including work; to communicate their needs to health carers; and implement advice about their pain. The ASES and CPSS address most of these aspects of self-efficacy, but do not include items that cover communication with their health carers. The CDSES covers all aspects of these self-efficacy criteria, whereas the PSEQ only addresses confidence to maintain everyday lives. The SES focuses purely on activities of daily living and items do not address any of the above. Additional research is needed before final decisions about the important aspects of self-efficacy can be made.  Patient-centred research should address the issue of what should be included in a truly comprehensive evaluation of pain-related self-efficacy.
Self-efficacy is not only related to specific behaviours but also to the beliefs that people have about how they can cope in adverse situations [3]. For a questionnaire to measure self-efficacy it is important that both components are covered in the questionnaire items. All the questionnaires we assessed featured items that ask about patients’ coping and about their beliefs in relation to their own behaviours.  However, it could be argued that this is not situation-specific enough. For example, “I can enjoy things, despite my pain”, may be too general a question, and may not tap beliefs about specific behaviours that have been affected by pain. Negative beliefs about a small range of very specific behaviours may be incredibly detrimental to patients’ coping and adjustment, but maybe obscured if items ask only general questions. Clearly it is difficult to measure self-efficacy using such a general tool when self-efficacy is sensitive to specific behaviours. One idea is to use a more patient-centred instrument in which individuals indicate the specific behaviours associated with their own personal self-efficacy, beliefs, behaviours and goals that also measures obstacles to effective coping, e.g., Measure Yourself Medical Outcome Profile (MYMOP) [39]. MYMOP aims to measure the outcomes that the patient considers the most important. On the first occasion the questionnaire is completed within the consultation, or with some confidential help. The patient chooses one or two symptoms that they are seeking help with, and that they consider to be the most important. The MYMOP has been shown to be  practical, reliable and sensitive to change [39]. This method can be applied to any measurement construct and is directly applicable to the patient, leading to high response and completion rates. There are several individualised measures available that could be used, one example of which is the MYMOP. However, to our knowledge there is no investigation of the use of the MYMOP to measure self efficacy. Furthermore, the MYMOP cannot be completed as a purely self administered tool, as it requires  initial guidance and so is not suitable for studies using only postal questionnaires. The method does however place high reliance on patient self-awareness of their problem areas and problematic in economic evaluations due to the individualised nature of the data.
Limitations
Despite our efforts to carry out a systematic and comprehensive search, it is possible that we missed important target articles. Our search was limited to Medline and PsycInfo, and although there is evidence that Medline is superior to other databases in its discriminating power and comprehensiveness [40], a wider search may have yielded further publications. We note, however, that we have reviewed the most commonly used instruments, and have been able to retrieve information on most aspects of their clinimetric properties. Another limitation is our focus on the label ‘self-efficacy’ alone: There is no doubt many overlapping concepts, such as patient enabling, locus of control, etc. However, generating all the overlapping terms and searching for them would yield an unmanageable amount of data. In addition, it is not clear how much shared and unique variance each concept has with self efficacy- such a conceptual analysis was beyond the scope of the current study.
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